PSA as a marker of androgen exposure during pubertal transition in healthy boys

Objective Prostate-specific antigen is an androgen-responsive protein used in adult men as a marker of prostate disease; however, its physiological rise during male puberty is poorly described. We evaluated whether serum prostate-specific antigen may serve as a biomarker of pubertal development in healthy boys and established age-specific reference intervals. Design Longitudinal cohort study. Methods The study included 104 healthy boys and 890 serum samples from the Copenhagen Puberty Study II. Serum prostate-specific antigen was measured by commercial immunoassay. Age-specific reference intervals were developed using generalised additive models for location, scale and shape. Total testosterone and sex hormone-binding globulin were measured by immunoassay. Free testosterone was calculated using the Vermeulen equation. Pubertal onset defined as testicular volume > 3 mL. Boys were categorised by genital stage 1 to 5, and group differences were analysed using linear mixed models. Results Prostate-specific antigen increased from 12 years of age, reaching a median concentration of 0.46 µg/L at 16.5 years, with a reference interval of 0.19 - 0.93 µg/L (model-estimated median ±2 SD). It was undetectable in prepubertal boys and at pubertal onset. A significant increase was observed from genital stage 3, indicating that prostate-specific antigen rose after pubertal onset and later than testosterone. Thresholds of > 3.06 nmol/L for total testosterone and > 36 pmol/L for free testosterone predicted detectable prostate-specific antigen. Conclusion Prostate-specific antigen increased with pubertal progression but was not detectable prior to the onset of puberty, suggesting that a threshold of androgen exposure is required for measurable production.

Authors

Institutions

Publication Details

Journal
European Journal of Endocrinology
Published
2026-11-19
DOI
https://doi.org/10.1093/ejendo/lvag212
Primary Topic
Hypothalamic control of reproductive hormones
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PSA as a marker of androgen exposure during pubertal transition in healthy boys

Linda Maria Hilsted, Anders Juul, Lise Aksglæde, Ruth Frikke‐Schmidt et al.
European Journal of Endocrinology
Hypothalamic control of reproductive hormones
article

PSA as a marker of androgen exposure during pubertal transition in healthy boys

Linda Maria Hilsted, Anders Juul, Lise Aksglæde, Ruth Frikke‐Schmidt, Andrés Felipe Østergaard Fritzbøger, Jørgen Holm Petersen
article en

Abstract

Objective Prostate-specific antigen is an androgen-responsive protein used in adult men as a marker of prostate disease; however, its physiological rise during male puberty is poorly described. We evaluated whether serum prostate-specific antigen may serve as a biomarker of pubertal development in healthy boys and established age-specific reference intervals. Design Longitudinal cohort study. Methods The study included 104 healthy boys and 890 serum samples from the Copenhagen Puberty Study II. Serum prostate-specific antigen was measured by commercial immunoassay. Age-specific reference intervals were developed using generalised additive models for location, scale and shape. Total testosterone and sex hormone-binding globulin were measured by immunoassay. Free testosterone was calculated using the Vermeulen equation. Pubertal onset defined as testicular volume > 3 mL. Boys were categorised by genital stage 1 to 5, and group differences were analysed using linear mixed models. Results Prostate-specific antigen increased from 12 years of age, reaching a median concentration of 0.46 µg/L at 16.5 years, with a reference interval of 0.19 - 0.93 µg/L (model-estimated median ±2 SD). It was undetectable in prepubertal boys and at pubertal onset. A significant increase was observed from genital stage 3, indicating that prostate-specific antigen rose after pubertal onset and later than testosterone. Thresholds of > 3.06 nmol/L for total testosterone and > 36 pmol/L for free testosterone predicted detectable prostate-specific antigen. Conclusion Prostate-specific antigen increased with pubertal progression but was not detectable prior to the onset of puberty, suggesting that a threshold of androgen exposure is required for measurable production.

European Journal of Endocrinology
University of Copenhagen (DK), Copenhagen University Hospital (DK), Rigshospitalet (DK)
Hypothalamic control of reproductive hormones
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon